Stock Research for SVA

Featured Broker: Ally Invest

Get the due diligence for another stock.


SVA Stock Chart & Research Data

The SVA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SVA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


SVA Due diligence Resources & Stock Charts

The SVA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SVA Detailed Price Forecast - CNN Money CNN View SVA Detailed Summary - Google Finance
Yahoo View SVA Detailed Summary - Yahoo! Finance Zacks View SVA Stock Research & Analysis -

Stock Analysis

TradeIdeas View SVA Trends & Analysis - Trade-Ideas Barrons View SVA Major Holders - Barrons
NASDAQ View SVA Call Transcripts - NASDAQ Seeking View SVA Breaking News & Analysis - Seeking Alpha
Spotlight View SVA Annual Report - OTC Report View SVA OTC Short Report -
TradeKing View SVA Fundamentals - TradeKing Charts View SVA SEC Filings - Bar Chart
WSJ View Historical Prices for SVA - The WSJ Morningstar View Performance/Total Return for SVA - Morningstar
MarketWatch View the Analyst Estimates for SVA - MarketWatch CNBC View the Earnings History for SVA - CNBC
StockMarketWatch View the SVA Earnings - StockMarketWatch MacroAxis View SVA Buy or Sell Recommendations - MacroAxis
Bullish View the SVA Bullish Patterns - American Bulls Short Pains View SVA Short Pain Metrics -

Social Media Mentions

StockTwits View SVA Stock Mentions - StockTwits PennyStocks View SVA Stock Mentions - PennyStockTweets
Twitter View SVA Stock Mentions - Twitter Invest Hub View SVA Investment Forum News - Investor Hub
Yahoo View SVA Stock Mentions - Yahoo! Message Board Seeking Alpha View SVA Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for SVA - Insider Cow View Insider Transactions for SVA - Insider Cow
CNBC View SVA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SVA - OTC Markets
Yahoo View Insider Transactions for SVA - Yahoo! Finance NASDAQ View Institutional Holdings for SVA - NASDAQ

Stock Charts

FinViz View SVA Stock Insight & Charts - StockCharts View SVA Investment Charts -
BarChart View SVA Stock Overview & Charts - BarChart Trading View View SVA User Generated Charts - Trading View

Latest Financial News for SVA

DOJ Closes Investigation of Sinovac
Posted on Monday September 17, 2018

BEIJING , Sept. 17, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China , today announced ...

The Daily Biotech Pulse: Merck's Keytruda Secures Approval For Expanded Label, ProPhase Labs Q2 Loss Narrows
Posted on Tuesday August 21, 2018

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 20) Avanos Medical Inc (NYSE: AVNS ) Becton Dickinson and Co (NYSE: ...

SEC Concludes Investigation of Sinovac
Posted on Monday August 20, 2018

BEIJING , Aug. 20, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China , today announced ...

Sinovac Raises $86.73 Million Through Private Placement Transaction
Posted on Tuesday July 03, 2018

BEIJING, July 3, 2018 /PRNewswire/ --Sinovac Biotech Ltd. (SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it has completed a private placement of its common shares (a "private investment in public equity," or "PIPE") with private investors Vivo Capital and Advantech Capital. Sinovac will receive gross proceeds of $86.73 million. The proceeds will be used to increase the Company's capabilities in research relating to quality control and to build additional production facilities to support the development and commercialization of sIPV-based combination vaccine and other new vaccine projects.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.